GLP-1 receptor agonist therapy and reduced incidence of rheumatic diseases: A propensity score-matched cohort study
Il est vital pour dtoxifier les tissus du mercure, du plomb et du cadmium
A patient who is 58 and weighs 250 pounds with an ideal weight of 150 lbs can expect to lose about 17 pounds during the first month
Obesity disrupts bone metabolism and leads to increased bone resorption, but GLP-1RAs can inhibit this damage and improve bone health by increasing the OPG/RANKL ratio, reducing osteoclast activity, and promoting bone formation GLP-1RAs and muscle GLP-1RAs and Muscle Atrophy In previous experiments, exendin-4 (Ex-4) inhibited the expression of myostatin (MSTN), atrophy-factor F-box only protein 32 (atrogin-1) and muscle ring finger protein 1 (MuRF-1) in dexamethasone-treated C2C12 myotubes.376,377,378 In a dexamethasone-induced muscle atrophy model, Ex-4 ameliorated muscle atrophy by inhibiting muscle atrophy factor and enhancing myogenic factors (MyoG and MyoD), thereby increasing muscle mass and function
All authors agree to be accountable for the content of the work
